Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The relentless construction activity taken out by the Ramky Infra Projects on the site is causing severe air and noise ...
In a report released today, Joon Lee from Truist Financial reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report). The company’s ...
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Hold rating on Caribou Biosciences (CRBU – Research Report), with a ...
Coeptis Inc. (Nasdaq: COEP) has taken a bold step forward in the fight against cancer by securing exclusive worldwide ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
Vertex Minerals Limited (ASX:VTX) (OTCMKTS:VTXXF) is pleased to announce the purchase of an Epiroc Boomer TD1 development and production rig to b ...
Vertex Minerals has bought an Epiroc Boomer TD1 drill rig for its Reward gold mine underground mining fleet. The company is taking pains to eliminate as ...
About 52 per cent of employees experience burnout due to poor work-life balance, showed a survey conducted in five states in ...
13h
Chalkbeat on MSNLinda McMahon’s first official K-12 visit: A Bronx charter schoolU.S. Education Secretary Linda McMahon took a tour of Vertex Partnership Academies founded by Ian Rowe, a senior fellow at ...
Vertex Pharmaceuticals received an upgrade from StockNews.com, moving from a “hold” to a “buy” rating. Other analysts have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results